Rchr
J-GLOBAL ID:200901052768251760   Update date: Feb. 01, 2024

Tanaka Toshihiro

タナカ トシヒロ | Tanaka Toshihiro
Affiliation and department:
Homepage URL  (1): http://www.med.fukuoka-u.ac.jp/interna1/index.php
Research field  (5): Tumor diagnostics and therapeutics ,  Healthcare management, medical sociology ,  Molecular biology ,  Tumor diagnostics and therapeutics ,  Hematology and oncology
Research keywords  (11): adenovirus vector ,  がん相談支援 ,  腫瘍内科学 ,  Antibody therapy ,  Anti-cancer drug treatment ,  Breast cancer ,  Cancer immunity ,  Medical Oncology ,  Medical information science ,  癌の遺伝子治療 ,  Development of antibody drugs against cancer
Research theme for competitive and other funds  (7):
  • 2017 - 2019 EphA2およびEGFRを標的とした、がん薬物療法の開発
  • 2015 - 2019 幹細胞選別及び評価チーム 神経再生チーム
  • 2010 - 2012 Pancreas-specific antibody production and development of pancreatic cancer therapy using virus vector
  • 2008 - 2010 Study on the Usefulness of the Novel Tumor Marker MK-1 in the Diagnosis and Therapy of Cancer
  • 2007 - 2009 膵癌標的化抗体を用いた遺伝子治療法の開発に関する研究
Show all
Papers (77):
  • Yoshimi JOKO, Kumiko OHKUBO, Toshihiro TANAKA, Yoichiro YOSHIDA, Hiroyuki INOUE, Teppei YAMADA,Hiroshi, MATSUZAKI, Masamitsu KURAKAZU, Makoto HAMASAKI, Kazuki NABESHIMA, et al. Current Status and Efforts of Cancer Genomic Medicine at Fukuoka University Hospital: As the Cancer Genomic Medicine Coordinator. Med. Bull. Fukuoka Univ. 2022. 49. 2. 107-113
  • Kohjiro Mashino, Maki Tanaka, Miki Yamaguchi, Reiki Nishimura, Yutaka Yamamoto, Hiroaki Ueo, Toshihiro Tanaka, Kenichiro Koga, Tomoyuki Yoshiyama, Shoshu Mitsuyama, et al. Longitudinal efficacy and safety of capecitabine and cyclophosphamide as early-line treatment in patients with metastatic breast cancer: A prospective cohort study by the Kyushu Breast Cancer Study Group, Japan. Annals of Cancer Research and Therapy. 2022. 30. 1. 38-44
  • Toshihiro Tanaka, Rika Sakai, Ilseung Choi, Junichi Tsukada, Hidenori Sasaki, Yoshiko Naito, Fumiaki Kiyomi, Yasushi Takamatsu, Kazuo Tamura. Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma. Scientific Reports. 2022. 12. 1
  • Shigeto Maeda, Keisei Anan, Kenichiro Koga, Sayaka Kuba, Hiroshi Yano, Yuichiro Kai, Reiki Nishimura, Uhi Toh, Miki Yamaguchi, Kohjiro Mashino, et al. Baseline neutrophil-to-lymphocyte ratio and absolute lymphocyte count in patients with HER2-negative breast cancer treated with eribulin may predict overall survival. Journal of Clinical Oncology. 2021. 39. 15_suppl. e13005-e13005
  • Toshiki Maeda, Hidenori Sasaki, Atsushi Togawa, Toshihiro Tanaka, Hisatomi Arima, Tohru Takata, Yasushi Takamatsu. Surveillance of the current situation regarding influenza vaccination according to medical oncologists in Japan. Cancer Science. 2021. 112. 1. 433-443
more...
MISC (28):
  • Reiki Nishimura, Uhi Toh, Maki Tanaka, Michiyo Saimura, Yasuhiro Okumura, Tsuyoshi Saito, Toshihiro Tanaka, Megumi Teraoka, Kazuo Shimada, Kazuhisa Katayama, et al. Correlation between HER2 related biomarkers (HER2, p95HER2, HER3, PTEN and PIK3CA) and treatment outcome of lapatinib plus capecitabine in HER2-positive metastatic breast cancer refractory to trastuzumab. JOURNAL OF CLINICAL ONCOLOGY. 2016. 34. 15
  • Yoichiro Yoshida, Masayasu Naito, Teppei Yamada, Naoya Aisu, Daibo Kojima, Toshiyuki Mera, Syu Tanimura, Toshihiro Tanaka, Keiko Naitoh, Kosei Yasumoto, et al. Clinical study on medical value of adoptive immunotherapy with chemotherapy for stage IV colorectal cancer (COMVI study). JOURNAL OF CLINICAL ONCOLOGY. 2016. 34. 4
  • Michinobu Yoshimura, Yosuke Ikari, Hiroo Katsuya, Atsushi Togawa, Toshitaka Goto, Toshihiro Tanaka, Kenji Ishitsuka, Tohru Takata, Yasushi Takamatsu, Kazuo Tamura. FEBRILE NEUTROPENIA(FN)AND D-INDEX. ANNALS OF ONCOLOGY. 2014. 25
  • Kentaro Ogata, Hiroo Katsuya, Akihiko Shirahashi, Yousuke Ikari, Michio Masaki, Toshitaka Goto, Toshihiro Tanaka, Kenji Ishitsuka, Yasushi Takamatsu, Kazuo Tamura. POLYPHARMACY IN ELDERLY CANCER PATIENTS. ANNALS OF ONCOLOGY. 2014. 25
  • 柿本 秀樹, 西田 恵美, 久保田 知佳, 上田 裕, 内山 将伸, 川原 義弘, 福田 まひる, 小田 真由美, 茂木 愛, 田中 俊裕, et al. 27-P4AM-107 外来化学療法室における薬学的介入事例の評価(がん薬物療法(服薬指導・情報提供),一般演題(ポスター),新時代を拓く医療薬学フロンティア). 日本医療薬学会年会講演要旨集. 2014. 24. 286-286
more...
Books (14):
  • フローチャート抗がん薬副作用 : 対応の流れと治療のポイントがわかる
    じほう 2020 ISBN:9784840752732
  • がん治療で起こる副作用・合併症の治療法と薬剤開発
    技術情報協会 2018 ISBN:9784861047237
  • プロフェッショナル がんナーシング2017年6号 トレンド☆エクスプレス いつものケアを見直そう! がん薬物療法の重大ニュース2017 これだけは
    MCメディカ ISSN 2185-7318 2017
  • 各領域専門医にきく 乳癌薬物療法ケースファイル
    南江堂 2014 ISBN:9784524266982
  • 医学のあゆみ くすりの副作用のすべて
    医歯薬出版 ISSN 0039-2359 2014
more...
Lectures and oral presentations  (74):
  • Current State and Satisfaction Surveys for User of Cancer Consultation Support Center at Fukuoka University Hospital.
    (2022)
  • Baseline neutrophil-to-lymphocyte ratio and absolute lymphocyte count in patients with HER2-negative breast cancer treated with eribulin may predict overall survival.
    (2021 ASCO Annual Meeting)
  • 電子カルテアクセスログを利用した医師の活動状況の把握と勤務管理
    (第22回日本医療マネジメント学会学術総会 2020)
  • 中枢神経原発リンパ腫(PCNSL)に対する治療成績の後方視的検討
    (第12回福岡県医学会総会 2020)
  • 進行・再発乳癌に対するCPT-11+S-1併用療法(IRIS)の安全性と有効性の検討
    (第23回バイオ治療法研究会学術集会 2019)
more...
Education (2):
  • 1999 - 2003 Fukuoka University Graduate School, Division of Medicine
  • 1988 - 1994 Fukuoka University Faculty of Medicine
Professional career (1):
  • 医学博士 (福岡大学)
Awards (1):
  • 2006/09/27 - 日本分子腫瘍マーカー研究会 第26回日本分子腫瘍マーカー研究会 奨励賞
Association Membership(s) (8):
Japan Society of Human Genetics ,  日本医療マネジメント学会 ,  Japanese Breast Cancer Society ,  Japan Association for Medical Informatics ,  The Japanese Society of Internal Medicine ,  Japanese Society of Medical Oncology ,  日本遺伝子治療学会 ,  Japanese Cancer Association
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page